U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187051187051Dose Response to Recombinant Factor VIIa When Administered for BleedCompletedNo Results AvailableCongenital Bleeding Disorder|HealthyDrug: activated recombinant human factor VIIhttps://ClinicalTrials.gov/show/NCT00104455
187052187052Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Rivastigminehttps://ClinicalTrials.gov/show/NCT00104442
187053187053GW873140 In Combination With Combivir In HIV Infected SubjectsTerminatedNo Results AvailableHuman Immunodeficiency Virus I Infection|HIV InfectionDrug: GW873140|Drug: Combivirhttps://ClinicalTrials.gov/show/NCT00104429
187054187054Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresCompletedHas ResultsEpilepsy|Seizures, Tonic-Clonic|Epilepsy, Tonic-ClonicDrug: lamotrigine (LAMICTAL) extended-release|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00104416
187055187055Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic ChemotherapyCompletedNo Results AvailableNausea and Vomiting, Chemotherapy-Induced|Chemotherapy-Induced Nausea and VomitingDrug: GW679769|Drug: Dexamethasone|Drug: Ondansetron Hydrochloridehttps://ClinicalTrials.gov/show/NCT00104403
187056187056Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick TestingCompletedNo Results AvailableType I HypersensitivityBiological: Grass MATA MPLhttps://ClinicalTrials.gov/show/NCT00104390
187057187057Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye PollenCompletedNo Results AvailableType I HypersensitivityBiological: Grass MATA MPLhttps://ClinicalTrials.gov/show/NCT00104377
187058187058A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)CompletedNo Results AvailableCancerDrug: MK0731https://ClinicalTrials.gov/show/NCT00104364
187059187059A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)(TERMINATED)TerminatedNo Results AvailableCancerDrug: VX-680 (an Aurora Kinase Inhibitor)https://ClinicalTrials.gov/show/NCT00104351
187060187060Study of FK778 in Renal Transplant Recipients With Untreated BK NephropathyTerminatedNo Results AvailableBK Polyomavirus|Kidney DiseasesDrug: FK778https://ClinicalTrials.gov/show/NCT00104338
187061187061Cytapheresis of Volunteer DonorsRecruitingNo Results AvailableCytapheresishttps://ClinicalTrials.gov/show/NCT00104325
187062187062Osteoarthritis: Weakness From InflammationCompletedNo Results AvailableOsteoarthritishttps://ClinicalTrials.gov/show/NCT00104312
187063187063Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedHas ResultsVasculitis|Wegener's Granulomatosis|Microscopic PolyangiitisDrug: Rituximab plus cyclophosphamide placebo (rituximab group)|Drug: Cyclophosphamide plus rituximab placebo (control group)|Drug: Azathioprine|Drug: Methylprednisolone (or other glucocorticoid)|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00104299
187064187064Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Solid TumorsTerminatedNo Results AvailableNeoplasmsDrug: Troxatylâ„¢ (Cytotoxic Chemotherapeutic)https://ClinicalTrials.gov/show/NCT00104286
187065187065Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNo Results AvailableDementia|Alzheimer's DiseaseDrug: Rasagilinehttps://ClinicalTrials.gov/show/NCT00104273
187066187066Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptinâ„¢ Treatment in Subjects With PhenylketonuriaCompletedNo Results AvailablePhenylketonuriasDrug: sapropterin dihydrochloridehttps://ClinicalTrials.gov/show/NCT00104260
187067187067Study to Evaluate the Safety and Efficacy of Phenoptinâ„¢ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine LevelsCompletedHas ResultsPhenylketonuriasDrug: sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterinhttps://ClinicalTrials.gov/show/NCT00104247
187068187068Study of rhASB in Patients With Mucopolysaccharidosis VICompletedHas ResultsMucopolysaccharidosis VIDrug: N-acetylgalactosamine 4-sulfatase|Drug: Placebo/rhASBhttps://ClinicalTrials.gov/show/NCT00104234
187069187069A Research Study of How Teens With and Without an Anxiety Disorder Make DecisionsCompletedNo Results AvailableAnxiety Disorders|Separation Anxiety Disorder|Phobic Disordershttps://ClinicalTrials.gov/show/NCT00104195
187070187070Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemir|Drug: insulin NPHhttps://ClinicalTrials.gov/show/NCT00104182
187071187071Idiopathic Anemia of Aging (IAA)TerminatedNo Results AvailableAnemia|AgingDrug: Epoetin Alfahttps://ClinicalTrials.gov/show/NCT00104169
187072187072Qigong Therapy for Individuals With Knee OsteoarthritisCompletedNo Results AvailableOsteoarthritisProcedure: External Qigong therapyhttps://ClinicalTrials.gov/show/NCT00104156
187073187073A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.WithdrawnNo Results AvailableMultiple SclerosisDrug: A4I Antagonisthttps://ClinicalTrials.gov/show/NCT00104143
187074187074Study of KOS-862 (Epothilone D) in Metastatic Prostate CancerTerminatedNo Results AvailableProstate CancerDrug: KOS-862https://ClinicalTrials.gov/show/NCT00104130
187075187075Study of XL999 in Adults With Solid TumorsCompletedNo Results AvailableCancerDrug: XL999https://ClinicalTrials.gov/show/NCT00104117
187076187076A Multiple Myeloma Trial in Patients With Bone MetastasesCompletedHas ResultsMultiple MyelomaDrug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00104104
187077187077Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsCompletedNo Results AvailableGlioblastoma MultiformeDrug: TP-38https://ClinicalTrials.gov/show/NCT00104091
187078187078Study Evaluating MYO-029 in Adult Muscular DystrophyCompletedNo Results AvailableBecker Muscular Dystrophy|Facioscapulohumeral Muscular Dystrophy|Limb-Girdle Muscular DystrophyDrug: MYO-029https://ClinicalTrials.gov/show/NCT00104078
187079187079Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow TransplantCompletedNo Results AvailableStomatitisDrug: CG53135-05, velaferminhttps://ClinicalTrials.gov/show/NCT00104065
187080187080Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)CompletedHas ResultsHepatitis C, ChronicBiological: peginterferon alfa-2b (PEG2b) (SCH 54031)|Drug: ribavirin (SCH 18908)https://ClinicalTrials.gov/show/NCT00104052

* Görseller ve İçerik tekif hakkına sahip olabilir